Tetrahydrofuran → HCID 59532390, compound

HRID 450970Notes

Reaction equation

HRID 450970 reaction equation
[CH2:1]([C@@:4]1([C:21]2[CH:26]=[CH:25][CH:24]=[CH:23][CH:22]=2)[O:9][C:8](=[O:10])[N:7]([C@H:11]([C:14]2[CH:19]=[CH:18][C:17]([Br:20])=[CH:16][CH:15]=2)[CH2:12][CH3:13])[CH2:6][CH2:5]1)[CH:2]=[CH2:3].[O:27]1CCCC1>>[Br:20][C:17]1[CH:16]=[CH:15][C:14]([C@@H:11]([N:7]2[CH2:6][CH2:5][C@:4]([CH2:1][CH2:2][CH2:3][OH:27])([C:21]3[CH:22]=[CH:23][CH:24]=[CH:25][CH:26]=3)[O:9][C:8]2=[O:10])[CH2:12][CH3:13])=[CH:19][CH:18]=1

Participants

3

Procedure

To a solution of (R)-6-allyl-3-((S)-1-(4-bromophenyl)propyl)-6-phenyl-1,3-oxazinan-2-one (100 mg, 0.242 mmol) in tetrahydrofuran (10 mL) was added BH3 THF (3 mL, 1 mol/L) at 0° C. under nitrogen. The formed mixture was stirred for 2 h. Then the reaction was quenched by water, followed by 3 mol/L NaOH and H2O2 (3 mL). The PH of the mixture was adjusted to <7 with 5% HCl. The organic phase was separated, extracted by EtOAc, and concentrated to give the crude product, which was purified by preparative HPLC to give (R)-3-((S)-1-(4-bromophenyl)propyl)-6-(3-hydroxypropyl)-6-phenyl-1,3-oxazinan-2-one (15 mg, 15%). LC-MS Method 3 tR=1.36, min, m/z=432, 434; 1H NMR (CDCl3): δ=0.99 (t, 3H), 1.29 (m, 1H), 1.63 (m, 1H), 1.98 (m, 4H), 2.20-2.42 (m, 2H), 2.48 (m, 1H), 3.08 (m, 1H), 3.49 (m, 1H), 5.30 (m, 1H), 6.92 (m, 2H), 7.26 (m, 4H), 7.35 (m, 2H).

Workup

  1. customThen the reaction was quenched by water
  2. customThe organic phase was separated
  3. extractionextracted by EtOAc
  4. concentrationconcentrated
  5. customto give the crude product, which
  6. customwas purified by preparative HPLC

Sources & evidence

ORD record
ord-c5dbe00f46224f27adaf837e9193cc47
Source dataset
uspto-grants-2013_07
Patent number
US08487094B2

Reaction notes

Loading…